LEYDIG CELL DYSFUNCTION AND GYNAECOMASTIA IN ADULT MALES TREATED WITH ALKYLATING AGENTS

1980 ◽  
Vol 12 (6) ◽  
pp. 553-556 ◽  
Author(s):  
N. M. FRIEDMAN ◽  
S. R. PLYMATE
1989 ◽  
Vol 7 (3) ◽  
pp. 304-309 ◽  
Author(s):  
F Aubier ◽  
F Flamant ◽  
R Brauner ◽  
J M Caillaud ◽  
J M Chaussain ◽  
...  

The testicular function of 30 adolescent or adult males having undergone polychemotherapy in childhood was assessed by means of a spermogram or testicular biopsy. At the time of examination, the patients were pubertal and had completed chemotherapy between 1 and 20 years previously (mean, 9 years). All patients who were prepubertal or intrapubertal at the time of treatment achieved normal puberty with normal growth. Twenty patients presented with azoospermia and/or severe disturbances in the germinal line on biopsy. This series confirms the toxicity of alkylating agents, in particular that of the mechlorethamine, vincristine, procarbazine, and prednisone combination (MOPP) and that of cyclophosphamide (CPM). However, dactinomycin, vinblastine, and vincristine did not appear to have a toxic effect on spermatogenesis. The prepubertal state did not protect the gonads of 19 patients who were prepubertal at diagnosis: 12 are now sterile as a result of the treatment. An increase in basal follicle-stimulating hormone (FSH) levels gives a good indication of testicular damage, although normal levels do not rule out the possibility of azoospermia.


2019 ◽  
Vol 10 ◽  
Author(s):  
Yiyan Wang ◽  
Chaobo Ni ◽  
Xiaoheng Li ◽  
Zhenkun Lin ◽  
Qiqi Zhu ◽  
...  

2018 ◽  
Vol 89 (6) ◽  
pp. 442-449
Author(s):  
Saila Laakso ◽  
Heli Viljakainen ◽  
Marita Lipsanen-Nyman ◽  
Ursula Turpeinen ◽  
Kaisa K. Ivaska ◽  
...  

Background: Previous studies suggest increased risk for hypoandrogenism and fractures in men with obesity. We aimed to describe the effects of severe childhood-onset obesity on the cross talk between metabolic state, testes, and skeleton at late puberty. Methods: A cohort of adolescent and young adult males with severe childhood-onset obesity (n = 21, mean age 18.5 years) and an age-matched control group were assessed for testicular hormones and X-ray absorptiometry-derived bone mass. Results: Current median body mass indexes for the obese and control subjects were 37.4 and 22.9. Severe early-onset obesity manifested with lower free testosterone (median [interquartile range] 244 [194–332] vs. 403 [293–463] pmol/L, p = 0.002). Lower insulin-like 3 (1.02 [0.82–1.23] vs. 1.22 [1.01–1.46] ng/mL, p = 0.045) and lower ratio of testosterone to luteinizing hormone (2.81 [1.96–3.98] vs. 4.10 [3.03–5.83] nmol/IU, p = 0.008) suggested disrupted Leydig cell function. The degree of current obesity inversely correlated with free testosterone (τ = –0.516, p = 0.003), which in turn correlated positively with bone area at all measurement sites in males with childhood-onset obesity. Conclusions: Severe childhood-onset obesity is associated with impaired Leydig cell function in young men and lower free testosterone may contribute to impaired skeletal characteristics.


1999 ◽  
Vol 17 (5) ◽  
pp. 1493-1493 ◽  
Author(s):  
S. J. Howell ◽  
J. A. Radford ◽  
W.D.J. Ryder ◽  
S. M. Shalet

PURPOSE: To evaluate testicular function in men after treatment with cytotoxic chemotherapy. PATIENTS AND METHODS: We measured testosterone, sex hormone–binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels in 209 men after treatment with mechlorethamine, vinblastine, procarbazine, and prednisone, hybrid chemotherapy, or high-dose chemotherapy and in 54 healthy age-matched controls. RESULTS: The mean age of the patients was 38 years (range, 19 to 68 years), and all patients had received chemotherapy between 1 and 22 years previously. Patients had significantly higher mean LH (7.9 v 4.1 IU/L; P < .0001) and FSH levels (18.8 v 3.1 IU/L; P < .0001) than controls. There was no significant difference in mean total testosterone level between the patients and controls, but there was a trend toward a lower mean testosterone/SHBG ratio in the patients (0.63 v 0.7; P = .08). Analysis of the hormonal parameters using a model that allowed for the effects of increasing age on testicular function showed evidence of significant recovery of gonadal function in the first 10 years after treatment. Fifty-two percent of patients had LH levels at or above the upper limit of normal, and 32% of patients had increased LH with testosterone levels in the lower half of the normal range, suggesting a degree of Leydig cell impairment. CONCLUSION: In a significant proportion of men, there is good evidence of Leydig cell dysfunction after cytotoxic chemotherapy. The clinical significance of this Leydig cell dysfunction is not clear, but some of these men may benefit from testosterone replacement. Further studies are warranted.


2016 ◽  
Vol 8 (10) ◽  
pp. 306 ◽  
Author(s):  
Taylor C Peak ◽  
Nora M Haney ◽  
William Wang ◽  
Kenneth J DeLay ◽  
Wayne J Hellstrom

Genetics ◽  
1986 ◽  
Vol 112 (3) ◽  
pp. 505-522
Author(s):  
Kazuo Fujikawa ◽  
Sohei Kondo

ABSTRACT DNA repair-defective alleles of the mei-9, mei-41, mus-104 and mus-101 loci of Drosophila melanogaster were introduced into stocks bearing the UZ and SZ marker sets. Males with the UZ marker set, z  1 (zeste allele) and w  +(TE) (genetically unstable white allele presumably caused by a transposable element), or the SZ marker set, z  1 and w  +R (semistable white allele caused by partial duplication of the w  + locus plus transposon insert), were exposed to EMS at the first instar. After emergence, adult males bearing red spots on lemon-yellow eyes were scored as flies with somatic reversions of w  +(TE) or w  +R. The relative mutabilities (relative values of reversion frequency at an equal EMS dose) of either w  +(TE) or w  +R in a repair-proficient strain and in mei-9, mei-41, mus-104 and mus-101 strains were 1:?1.2:0.3:0.3:0.7, despite the fact that w  +(TE) reverted two to three times as frequently as w  +R under both the repair-proficient and repair-deficient genetic conditions. Similarly, after treatment with MMS, MNNG and ENNG, w  +(TE) was somatically more mutable in the mei-9 strain and less mutable in the mei-41 and mus-104 strains than in the repair-proficient strain. From these results, we propose that mutagenic lesions produced in DNA by treatment with these chemicals are converted to mutant DNA sequences via the error-prone repair mechanisms dependent on the products of the genes mei-41  + (mei-41 and mus-104 being alleles of the same locus) and mus-101  +, whereas they are eliminated by mei-9  +-dependent excision repair. In contrast to the approximately linear responses of induced reversions of w  +(TE) with ENNG in the repair-proficient, mei-9, and mei-41 strains, seemingly there were dosage insensitive ranges for induced reversion with MNNG in the repair-proficient and mei-41 strains, but not for reversion in the mei-9 strain; w  +(TE) in the mus-104 strain was virtually nonmutable with MNNG and ENNG. These results suggest that O  6-methylguanine (O  6MeG) produced in DNA with MNNG, but not O  6-ethylguanine produced with ENNG, is almost completely repaired in a low dose range by constitutive activity of DNA O  6MeG transmethylase. From the distribution of clone sizes of spontaneous revertant spots and other data, we propose that both w  +(TE) and w  +R have a similar tendency to spontaneously revert more frequently at early rather than at late developmental stages, probably reflecting a common property of their inserted transposons.


1987 ◽  
Vol 64 (6) ◽  
pp. 1194-1198 ◽  
Author(s):  
JOHN D. BOOTH ◽  
GEORGE R. MERRIAM ◽  
RICHARD V. CLARK ◽  
D. LYNN LORIAUX ◽  
RICHARD J. SHERINS

2001 ◽  
Vol 28 (5) ◽  
pp. 497-502 ◽  
Author(s):  
R Chatterjee ◽  
PD Kottaridis ◽  
HH McGarrigle ◽  
J Eliahoo ◽  
N McKeag ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document